Brief: CHMP Recommends Granting Marketing Authorisation For Frehemgo, Vaxrabeo, Adcomfo & Pebrilzo
BRIEF-CHMP Recommends Granting Marketing Authorisation For Frehemgo, Vaxrabeo, Adcomfo & Pebrilzo Sept 18 (Reuters) - EMA's CHMP:
EMA'S CHMP: RECOMMENDED GRANTING A MARKETING AUTHORISATION FOR FREHEMGO (DENECIMIG)
EMA'S CHMP: RECOMMENDED GRANTING A MARKETING AUTHORISATION FOR VAXRABEO
EMA'S CHMP: RECOMMENDS GRANTING MARKETING AUTHORISATION FOR ADCOMFO & PEBRILZO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novo Nordisk A/S
See all newsFocus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Factbox: Anthropic's public benefit fund and how it compares with other big philanthropic efforts
Novo's CagriSema helped women lose 25% of weight on average, analysis shows
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Factbox: Major drugmakers turn to China for licensing deals